Farms.com Home   News

Threat of ASF Prompts Pork Producers to Refocus on Biosecurity

The Chair of Swine Innovation Porc's Science Advisory Board says the threat of African Swine Fever has refocussed the attention of pork producers on biosecurity. Biosecurity has been identified by a Swine Innovation Porc Special Research Advisory group as one of six African Swine Fever research priorities.

Dr. Andrew Van Kessel, the Associate Director Research with VIDO-InterVac and the Chair of Swine Innovation Porc's Science Advisory Board, observes ASF has caused producers to re-think their biosecurity plans and confirm their practices will be effective and are being followed.

Clip-Dr. Andrew Van Kessel-VIDO-InterVac:

Reality is African Swine Fever has caused us to think more about feed ingredients, particularly the prevalence of this virus in Asia, the import of lots of feed ingredients from Asia. Those that are arriving from Asia are particularly of concerns and so producers are looking at the sources of feed ingredients, working with their suppliers to make sure they know where those feed ingredients are coming from and ensuring that there's a quarantine period so that the period of time after exposure will result will eventually result in death of the virus and minimise the risk.

The other one on the biosecurity side is the wild boar issue. We have a problem with wild boars an invasive species in North American and certainly in Canada.

Where wild boar are present, they can carry ASF and so there may be some attention for producers who operate facilities in those areas to ensure the grounds are excluding wild boar and the opportunity for transmission to a commercial herd.

Source : Farmscape

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.